Bioinformatics and Pathway Enrichment Analysis Identified Hub Genes and Potential Biomarker for Gastric Cancer Prognosis

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Jun 26

PMID 37361568

Authors

Elham Darang

Zahra Pezeshkian

Seyed Ziaeddin Mirhoseini

Shahrokh Ghovvati

Affiliations

Soon will be listed here.

Abstract

Introduction: Gastric cancer is one of the most common cancers in the world. This study aimed to identify genes, biomarkers, and metabolic pathways affecting gastric cancer using bioinformatic analysis and meta-analysis.

Methods: Datasets containing gene expression profiles of tumor lesions and adjacent non-tumor mucosa samples were downloaded. Common differentially expressed genes between data sets were selected to identify hub genes and further analysis. Gene Expression Profiling and Interactive Analyses (GEPIA) and the Kaplan-Meier method were used to further validate the expression level of genes and plot the overall survivalcurve, respectively.

Results And Disscussion: KEGG pathway analysis showed that the most important pathway was enriched in ECM-receptor interaction. Hub genes includingCOL1A2, FN1, BGN, THBS2, COL5A2, COL6A3, SPARC and COL12A1 wereidentified. The top interactive miRNAs including miR-29a-3p, miR-101-3p,miR-183-5p, and miR-15a-5p targeted the most hub genes. The survival chart showed an increase in mortality in patients with gastric cancer, which shows the importance of the role of these genes in the development of the disease and can be considered candidate genes in the prevention and early diagnosis of gastric cancer.

Citing Articles

Genetic characterization and selection of litter size traits of Guizhou Black goat and Meigu goat.

Zhao Y, Han Y, Yang Y, Yuan C, Long Y, Xiao W PLoS One. 2024; 19(11):e0313297.

PMID: 39509359 PMC: 11542855. DOI: 10.1371/journal.pone.0313297.

A Bioinformatics Investigation of Hub Genes Involved in Treg Migration and Its Synergistic Effects, Using Immune Checkpoint Inhibitors for Immunotherapies.

Kim N, Na S, Pyo J, Jang J, Lee S, Kim K Int J Mol Sci. 2024; 25(17).

PMID: 39273290 PMC: 11395080. DOI: 10.3390/ijms25179341.

Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approach.

Beg A, Parveen R, Fouad H, Yahia M, Hassanein A J Ovarian Res. 2024; 17(1):86.

PMID: 38654363 PMC: 11036584. DOI: 10.1186/s13048-024-01402-7.

[Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis].

Liang Y, Lai Y, Yuan Y, Yuan W, Zhang X, Zhang B Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(3):605-616.

PMID: 38597453 PMC: 11006697. DOI: 10.12122/j.issn.1673-4254.2024.03.23.

An R package for Survival-based Gene Set Enrichment Analysis.

Deng X, Thompson J Res Sq. 2023; .

PMID: 37841872 PMC: 10571627. DOI: 10.21203/rs.3.rs-3367968/v1.

References

Jamaspishvili T, Berman D, Ross A, Scher H, De Marzo A, Squire J . Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol. 2018; 15(4):222-234. PMC: 7472658. DOI: 10.1038/nrurol.2018.9. View

Cao L, Chen Y, Zhang M, Xu D, Liu Y, Liu T . Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis. PeerJ. 2018; 6:e5180. PMC: 6033081. DOI: 10.7717/peerj.5180. View

Sun Y, Zhao C, Ye Y, Wang Z, He Y, Li Y . High expression of fibronectin 1 indicates poor prognosis in gastric cancer. Oncol Lett. 2020; 19(1):93-102. PMC: 6923922. DOI: 10.3892/ol.2019.11088. View

Wang R, Fu L, Li J, Zhao D, Zhao Y, Yin L . Microarray Analysis for Differentially Expressed Genes Between Stromal and Epithelial Cells in Development and Metastasis of Invasive Breast Cancer. J Comput Biol. 2020; 27(12):1631-1643. DOI: 10.1089/cmb.2019.0154. View

Bai F, Jiu M, You Y, Feng Y, Xin R, Liu X . miR‑29a‑3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels. Mol Med Rep. 2018; 17(6):8145-8152. PMC: 5983988. DOI: 10.3892/mmr.2018.8896. View

Xie X, Liu X, Zhang Q, Yu J . Overexpression of collagen VI α3 in gastric cancer. Oncol Lett. 2014; 7(5):1537-1543. PMC: 3997710. DOI: 10.3892/ol.2014.1910. View

Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza M . Treatment of gastric cancer. World J Gastroenterol. 2014; 20(7):1635-49. PMC: 3930964. DOI: 10.3748/wjg.v20.i7.1635. View

Joshi S, Badgwell B . Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021; 71(3):264-279. PMC: 9927927. DOI: 10.3322/caac.21657. View

Zhang H, Sun Z, Li Y, Fan D, Jiang H . MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother. 2017; 88:285-292. DOI: 10.1016/j.biopha.2017.01.023. View

10.

Ma J, Ma Y, Chen S, Guo S, Hu J, Yue T . SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis. Biochem Biophys Res Commun. 2021; 558:134-140. DOI: 10.1016/j.bbrc.2021.04.009. View

11.

Ding Y, Sun S, Zhao G . COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis. Medicine (Baltimore). 2021; 100(7):e24561. PMC: 7899835. DOI: 10.1097/MD.0000000000024561. View

12.

Li J, Ding Y, Li A . Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. World J Surg Oncol. 2016; 14(1):297. PMC: 5126984. DOI: 10.1186/s12957-016-1056-5. View

13.

Liu X, Wu J, Zhang D, Bing Z, Tian J, Ni M . Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis. Front Genet. 2018; 9:265. PMC: 6056647. DOI: 10.3389/fgene.2018.00265. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

15.

Zhang S, Xiang X, Liu L, Yang H, Cen D, Tang G . Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer. Cancer Manag Res. 2021; 13:8929-8951. PMC: 8643151. DOI: 10.2147/CMAR.S341485. View

16.

Ng K, Shea Q, Wong T, Luk S, Tong M, Lo C . Chemotherapy-Enriched THBS2-Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications. Adv Sci (Weinh). 2021; 8(5):2002483. PMC: 7927606. DOI: 10.1002/advs.202002483. View

17.

Sun C, Yuan Q, Wu D, Meng X, Wang B . Identification of core genes and outcome in gastric cancer using bioinformatics analysis. Oncotarget. 2017; 8(41):70271-70280. PMC: 5642553. DOI: 10.18632/oncotarget.20082. View

18.

Fischer H, Stenling R, Rubio C, Lindblom A . Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis. 2001; 22(6):875-8. DOI: 10.1093/carcin/22.6.875. View

19.

Satelli A, Li S . Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011; 68(18):3033-46. PMC: 3162105. DOI: 10.1007/s00018-011-0735-1. View

20.

Liu L, Chen F, Xiu A, Du B, Ai H, Xie W . Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical Analysis. Asian Pac J Cancer Prev. 2018; 19(4):969-975. PMC: 6031768. DOI: 10.22034/APJCP.2018.19.4.969. View